Eris Lifesciences Limited (BOM:540596)
India
· Delayed Price · Currency is INR 1,328.40
-31.70 (-2.33%)
At close: Mar 9, 2026
Eris Lifesciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 184,014 | 192,990 | 114,719 | 77,801 | 93,615 | 82,147 | Upgrade
|
| Market Cap Growth | 6.85% | 68.23% | 47.45% | -16.89% | 13.96% | 64.00% | Upgrade
|
| Enterprise Value | 211,278 | 221,970 | 121,268 | 80,085 | 92,600 | 80,183 | Upgrade
|
| Last Close Price | 1328.40 | 1416.50 | 836.45 | 568.82 | 677.98 | 589.96 | Upgrade
|
| PE Ratio | 42.69 | 54.85 | 29.26 | 20.36 | 23.05 | 23.13 | Upgrade
|
| PS Ratio | 6.00 | 6.70 | 5.76 | 4.68 | 7.06 | 6.89 | Upgrade
|
| PB Ratio | 5.25 | 5.90 | 3.56 | 3.50 | 4.91 | 5.21 | Upgrade
|
| P/TBV Ratio | - | - | - | - | 8.10 | 10.28 | Upgrade
|
| P/FCF Ratio | - | 21.21 | 32.15 | - | 36.39 | 23.50 | Upgrade
|
| P/OCF Ratio | - | 18.12 | 23.60 | 26.67 | 24.75 | 21.89 | Upgrade
|
| EV/Sales Ratio | 6.89 | 7.71 | 6.09 | 4.82 | 6.98 | 6.72 | Upgrade
|
| EV/EBITDA Ratio | 17.24 | 22.09 | 18.30 | 15.23 | 19.18 | 18.82 | Upgrade
|
| EV/EBIT Ratio | 25.99 | 31.59 | 24.53 | 18.99 | 21.81 | 20.69 | Upgrade
|
| EV/FCF Ratio | - | 24.39 | 33.98 | - | 36.00 | 22.94 | Upgrade
|
| Debt / Equity Ratio | 0.68 | 0.76 | 0.86 | 0.40 | 0.05 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.95 | 2.44 | 4.13 | 1.66 | 0.19 | 0.04 | Upgrade
|
| Debt / FCF Ratio | - | 2.72 | 7.79 | - | 0.36 | 0.05 | Upgrade
|
| Net Debt / Equity Ratio | 0.66 | 0.70 | 0.45 | 0.36 | -0.06 | -0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.91 | 2.26 | 2.18 | 1.53 | -0.25 | -0.26 | Upgrade
|
| Net Debt / FCF Ratio | - | 2.50 | 4.04 | -1.47 | -0.46 | -0.32 | Upgrade
|
| Asset Turnover | - | 0.41 | 0.37 | 0.56 | 0.65 | 0.70 | Upgrade
|
| Inventory Turnover | - | 2.80 | 2.47 | 2.90 | 2.49 | 2.95 | Upgrade
|
| Quick Ratio | - | 0.56 | 0.75 | 1.22 | 1.99 | 1.78 | Upgrade
|
| Current Ratio | - | 0.89 | 0.91 | 1.73 | 3.14 | 2.80 | Upgrade
|
| Return on Equity (ROE) | - | 11.54% | 14.59% | 18.12% | 23.29% | 24.72% | Upgrade
|
| Return on Assets (ROA) | - | 6.24% | 5.77% | 8.87% | 12.92% | 14.31% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.80% | 10.55% | 11.84% | 16.19% | 23.95% | 26.52% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 12.40% | 11.00% | 13.10% | 20.50% | 23.20% | Upgrade
|
| Earnings Yield | 2.34% | 1.82% | 3.42% | 4.91% | 4.34% | 4.32% | Upgrade
|
| FCF Yield | - | 4.71% | 3.11% | -7.07% | 2.75% | 4.26% | Upgrade
|
| Dividend Yield | - | 0.52% | - | 1.29% | 0.89% | 0.93% | Upgrade
|
| Payout Ratio | - | 28.44% | - | 26.14% | 20.10% | 21.03% | Upgrade
|
| Buyback Yield / Dilution | -0.03% | -0.09% | -0.03% | -0.19% | -0.02% | 1.03% | Upgrade
|
| Total Shareholder Return | -0.03% | 0.43% | -0.03% | 1.10% | 0.86% | 1.97% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.